KPV Peptide Price in Australia: A$84.99 for 10mg

Current KPV price in Australia

Pillar Research lists KPV 10mg at A$84.99 per vial, available to preorder with a stated dispatch window. The product page carries live price and status; this article explains what the figure covers.

What the listed price includes

• Declared strength: 10mg of lyophilised KPV research material per vial.
• Reported purity: 99.765% for batch JUNE-2026-198517, analysed by Janoshik.
• Measured net content: 12.02mg, reported against a 10mg pack size.
• Identity result: Sample reported as KPV, recorded separately from purity.
• Batch record: a batch-specific certificate of analysis tied to the released material.
• Local fulfilment: Australian dispatch once the preorder window closes.

Why a three-amino-acid peptide is not the cheapest thing on the shelf

KPV is a tripeptide: lysine, proline, valine. Short sequences are simpler to synthesise than long ones, so buyers often expect the price to track the amino-acid count. It does not, and the reasons are worth understanding before comparing offers.

• Purification, not synthesis, dominates. Reaching a figure like 99.765% requires chromatographic separation regardless of chain length.
• Small vials carry fixed costs. Lyophilisation, vialling, sealing and batch testing cost roughly the same for a 10mg vial as a 50mg one.
• Analysis is per batch, not per milligram. One report is commissioned for a batch, so a small batch carries the whole cost of testing.
• Identity work is separate. Confirming the sequence is a different analysis from measuring purity.

The practical consequence: an unusually cheap KPV offer is more likely to be missing analysis than to reflect efficient synthesis. The COA review checklist covers what a complete report should contain.

What a KPV listing should tell you before you compare it

Listings for KPV vary widely in what they disclose, and the gaps are usually in the same places. Before treating two prices as comparable, check that both pages answer all five of these.

• Strength per vial, stated in milligrams rather than implied by the price tier.
• A batch number that appears on both the listing and the certificate.
• An analysis date, so the report can be tied to current rather than historical stock.
• The testing laboratory, named rather than described as “third-party”.
• Stock or preorder status, with a dispatch window if the vial is not held.

A listing missing three or more of these is not cheaper on equivalent terms; it is quoting a different, less documented product.

Buying KPV on its own or inside the KLOW blend

KPV is also one of the four components of the KLOW blend, which raises an obvious question when comparing prices. The released KLOW batch reports GHK-Cu 66.97mg; TB-500 11.41mg; BPC-157 11.23mg; KPV 10.35mg, so the KPV fraction inside a KLOW vial is documented rather than assumed.

The difference that matters commercially is documentation, not chemistry. A standalone KPV vial carries its own purity figure — 99.765% for the current batch. The blend’s report states identity and amount per component but no single purity percentage, because that figure has no coherent meaning across a four-peptide mixture. If a per-component purity record is needed, the standalone vial is the format that provides it.

What the research literature covers

KPV is the C-terminal fragment of alpha-melanocyte-stimulating hormone. The parent molecule has been studied for anti-inflammatory signalling,^[1] and reviews have examined alpha-MSH and its related tripeptides across in-vitro and in-vivo systems.^[2] KPV itself has been examined in murine models of intestinal inflammation^[3] and in work describing PepT1-mediated uptake in intestinal cells.^[4]

These are cell and animal findings. We have not identified published clinical trials establishing KPV’s safety, efficacy or pharmacokinetics in people, so the evidence should be read as preliminary laboratory and animal research rather than as a basis for human use. The KPV research overview goes through the studies and their limits in detail.

Price, stock and dispatch can change

KPV is a preorder line, so the dispatch window is the figure to check alongside price. Verify the live A$84.99 price, current preorder window and batch report on the KPV product page before ordering.

Compliance reminder

KPV is supplied for research and educational purposes only. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and must not be consumed by humans or animals. All experimental use should follow institutional safety guidelines and relevant regulations.

Comparing KPV offers? View KPV in Australia. For related research, see the KPV research overview and the KLOW blend identity review, which covers KPV as a blend component.